scholarly article | Q13442814 |
P356 | DOI | 10.3899/JRHEUM.100668 |
P698 | PubMed publication ID | 21239756 |
P50 | author | Gyula Szegedi | Q1295375 |
Yehuda Shoenfeld | Q1515807 | ||
P2093 | author name string | Pál Soltész | |
Zoltán Szekanecz | |||
György Paragh | |||
György Kerekes | |||
Sándor Sipka | |||
Ildikó Seres | |||
János Kappelmayer | |||
Sándor Szántó | |||
Nóra Bodnár | |||
Zsuzsanna Gyurcsik Némethné | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ankylosing spondylitis | Q52849 |
vascular disease | Q1266890 | ||
P304 | page(s) | 723-729 | |
P577 | publication date | 2011-01-15 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | Assessment of subclinical vascular disease associated with ankylosing spondylitis | |
P478 | volume | 38 |
Q88651282 | Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance |
Q90479817 | Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis |
Q89417229 | Association between arterial stiffness, disease activity and functional impairment in ankylosing spondylitis patients: a cross-sectional study |
Q50355546 | Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. |
Q38025994 | Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights |
Q64079453 | Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis |
Q38936667 | Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis. |
Q89444267 | Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls |
Q34072179 | Endothelial dysfunction in chronic inflammatory diseases |
Q64082696 | Endothelial dysfunction in patients with ankylosing spondylitis |
Q87476515 | Epicardial adipose tissue thickness in patients with ankylosing spondylitis |
Q48007635 | Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease |
Q64111747 | Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis |
Q88936686 | Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk |
Q34731291 | Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study. |
Q35142805 | Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study. |
Q36727576 | Is there a relationship between endothelial nitric oxide synthase gene polymorphisms and ankylosing spondylitis? |
Q55031386 | Is triglyceride/HDL ratio a reliable screening test for assessment of atherosclerotic risk in patients with chronic inflammatory disease? |
Q27694518 | Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations |
Q58765329 | Microvascular dysfunction in ankylosing spondylitis is associated with disease activity and is improved by anti-TNF treatment |
Q38911778 | Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis |
Q55263498 | Retinal Vessel Diameters and Physical Activity in Patients With Mild to Moderate Rheumatic Disease Without Cardiovascular Comorbidities. |
Q34979110 | Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study |
Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
Q35993667 | Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study |
Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
Q38519523 | Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. |
Q34164481 | Validated methods for assessment of subclinical atherosclerosis in rheumatology |
Q55352845 | Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors. |
Search more.